The short version
- A fifteen-year study tracking cognitive health in Pittsburgh neighborhoods has been terminated due to federal grant cancellations.
- Approximately six hundred participants may not receive promised feedback on their Alzheimer’s risk assessments.
- Critics argue the move undermines efforts to address racial disparities in dementia research and treatment.
A significant longitudinal study focused on cognitive health and aging in Pittsburgh has been abruptly terminated, leaving hundreds of participants without the medical feedback they were promised. The project, known as Phresh, began over fifteen years ago as an investigation into food deserts but evolved into a comprehensive examination of life course wellbeing and cognitive decline among low-income, majority Black communities. Researchers had collected extensive data through surveys, wearable monitors, and clinical assessments, including specific tests for Alzheimer’s disease.
The cancellation stems from broader funding cuts implemented by the Trump administration at the National Institutes of Health. More than five thousand medical research grants have been frozen, canceled, or disrupted as part of an effort to realign scientific priorities. Officials labeled certain studies, including this one, as focused on diversity, equity, and inclusion initiatives rather than core scientific inquiry. The decision forced researchers to shut down operations ninety days after notification, a timeline that proved insufficient for completing critical final steps.
Tamara Dubowitz, a professor at the University of Pittsburgh and primary investigator on the study, noted that the abrupt end prevents the team from conducting necessary cognitive adjudications. These processes involve neuropsychologists and geriatric psychiatrists interpreting test results to provide accurate diagnoses or risk assessments. Without funding to pay these specialists, the researchers cannot fulfill their commitment to share individual results with participants who contributed years of personal data.
Roderick Blair, a seventy-year-old retired emergency preparedness worker from the Homewood neighborhood, represents many in the study group. Initially skeptical of research efforts that historically marginalized Black communities, Blair eventually trusted the team after they demonstrated long-term commitment to the area. He participated in detailed surveys covering childhood experiences and trauma, wore sleep monitors, and completed cognitive tests twice. For him and others, the cancellation feels like a breach of trust and a form of retribution against community-engaged science.
The implications extend beyond individual participants to the broader understanding of Alzheimer’s disease disparities. Nearly seven million Americans live with the condition, with Black individuals facing nearly double the risk compared to white populations. Historically, this disparity was often framed as an individual risk factor. However, recent research suggests that structural forces such as neighborhood divestment and the cumulative effects of discrimination play significant roles in health outcomes.
Data from the Phresh study aimed to capture these complex interactions by documenting how environmental and social factors influence cognitive health over time. The participants lived just miles from a major Alzheimer’s research hub, yet their experiences highlighted gaps in traditional clinical trials. Existing studies often skew toward wealthy and white participants, with fewer than ten percent of brain-imaging studies reporting race data at all.
The termination of this grant contributes to a growing concern about the erosion of diverse datasets in medical research. By halting projects that specifically target underrepresented populations, federal agencies risk delaying vital diagnoses and treatments for communities already facing higher disease burdens. Early diagnosis is crucial for managing Alzheimer’s, making the loss of this feedback loop particularly damaging.
As the scientific community grapples with these changes, questions remain about how many other studies will be affected and what long-term consequences this shift in funding priorities will have on public health. The Phresh study serves as a case study in the tension between political directives and established research methodologies, highlighting the potential costs of disrupting longitudinal data collection efforts.
Researchers and advocates continue to monitor the situation, emphasizing the need for transparency and accountability in how federal funds are allocated. The story of Blair and his neighbors underscores the human element behind statistical disparities, reminding policymakers that scientific progress relies on sustained engagement with diverse populations rather than short-term political agendas.
Sources behind this briefing
Go to the original reporting
- The Guardian US↗‘Clear retribution’: dismay as key Alzheimer’s study cancelled amid Trump attacks on science
